Survival evaluation of children with acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munich trial;Avaliação da sobrevida de crianças com leucemia linfocítica aguda tratadas com o protocolo Berlim-Frankfurt-Munique

Jornal de Pediatria

Volumn 79, Issue 2, 2003, Pages 149-158

  Laks, Dani ^a,d   Longhi, Fernanda ^a   Bernardes Wagner, Mário ^b   Ramos Garcia, Pedro Celiny ^c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Universidade de São Paulo ^*  (Brazil)

Author keywords

Acute; Leukemia; Lymphocytic; Survival analysis

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PREDNISONE; TIOGUANINE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; DEATH; DEVELOPED COUNTRY; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PROBABILITY; PROGNOSIS; SURVIVAL RATE;

EID: 0038247941     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0021-75572003000200010     Document Type: Article

References (20)

1. a ed. Philadelphia: W.B. Saunders Company, 1998.p.1245-85.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. Cancer J Clin 1997;47:5-27.
3. Sandler DP, Ross JA. Epidemiology of acute leukemia in children and adults. Semin Oncol 1997;24:3-16.
4. a. ed. Philadelphia: Churchill Livingstone; 2000.p.1070-8.
5. Camitta BM, Pullen J, Murphy S. Biology and treatment of acute lymphoblastic leukemia in children. Sem Oncol 1997;24:83-91.
6. a ed. Philadelphia: Churchill Livingstone; 2000. p.1070-8.
7. Sackmann-Muriel F, Felice MS, Zubizarreta PA, Alfaro E, Gallego M, Rossi J, et al. Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM'90 protocol: lack of improvement in high-risk group. Leuk Res 1999;23:331-40.
8. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and of cranial radiotherapy: results of trial ALL-BFM 90. Blood 2000;95:3310-22.
9. Viana MB, Murao M, Ramos G, Oliveira HM, Carvalho RI, Bastos M, et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child 1994;71:304-10.
10. Kleinbaum DG. Kaplan-Meier survival curves and the log-rank test. In: Dietz K, Gail M, Krickeberg K, Singer B. Statistics in the Health Sciences. New York: Springer-Verlag; 1996. p.1-44.
11. Kleinbaum DG. The Cox proportional hazards model and its characteristics. In: Dietz K, Gail M, Krickeberg K, Singer B. Statistics in the Health Sciences. New York: Springer-Verlag; 1996. p.1-44.
12. Conter V, Aricó M, Valsecchi MG, Rizzari C, Testi A, Miniero R, et al. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Haematologica 1998;83:791-9.
13. Shuster JJ, Wacker P, Pullen J, Humbert J, Land VJ, Mahoney DH Jr, et al. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol 1998;16:2854-63.
14. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-15.
15. Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 2001;97:1211-8.
16. Hann IM, Richards SM, Eden OB, Hill FG. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party. Leukemia 1998;12:1249-55.
17. Gaynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review. Cancer 1997;80:1717-26.
18. Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, et al. Cytoreduction and prognosis in acute lymphoblastic leukemia - the importance of early marrow response: report from the Children's Cancer Group. J Clin Oncol 1996;14:389-98.
19. Lange BJ. The ultra low risk child with acute lymphoblastic leukemia. American Society of Hematology Education Program Book 2000;286-91.
20. Pui CH, Sallan S, Relling MV, Masera G, Evans WE. International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November-1 December 2000. Leukemia 2001;15:707-15.